Drug Shortage Report for LEVITRA
| Report ID | 64770 |
| Drug Identification Number | 02250470 |
| Brand name | LEVITRA |
| Common or Proper name | Vardenafil tablets |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-11-09 |
| Actual start date | |
| Estimated end date | 2019-01-31 |
| Actual end date | 2018-12-28 |
| Shortage status | Resolved |
| Updated date | 2019-01-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-01-14 | French | Compare |
| v4 | 2019-01-14 | English | Compare |
| v3 | 2018-11-10 | English | Compare |
| v2 | 2018-10-18 | French | Compare |
| v1 | 2018-10-18 | English | Compare |
Showing 1 to 5 of 5